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Background: Causes of constrictive pericarditis and predictors of peri-operative 
outcome following pericardiectomy are not clearly elucidated, especially in Africa, 
where disease characteristics differ from developed countries. Furthermore, the 
impact of HIV/AIDS on pericardial constriction and outcomes following surgery is 
unknown. We set out to investigate the causes of constrictive pericarditis, the 
outcomes after pericardiectomy and the predictors of mortality in Cape Town, 
South Africa during a 22-year period of high HIV/AIDS prevalence. 
Methods: A retrospective review of records of all patients who underwent 
pericardiectomy for constrictive pericarditis at Groote Schuur Hospital from 1 
January 1990 to 31 December 2012 was performed. 
Results: Of 121 patients, thirty six (29.8%) had proven tuberculosis, 74 (61.2%) 
presumed tuberculosis, six (5%) idiopathic, and 5 (4%) miscellaneous causes of 
constrictive pericarditis. Seventeen patients (14%) died peri-operatively with low 
cardiac output syndrome the main cause of mortality. In multivariable analysis, 
serum sodium (HR=0.88, 95%CI 0.80-0.97 p=0.009) and pre-operative New York 
Heart Association (NYHA) class IV (HR=3.42, 95%CI 1.29-9.08, p=0.014; compared 
with combined class I-III) were independent predictors of early mortality. There 
were 14 (11.6%) HIV positive patients with a mean CD4 cell count of 284 ± 133 
cells/µl. No early deaths occurred in the HIV positive patients.  
Conclusion: Tuberculosis is the main cause of constrictive pericarditis in South 
Africa. Despite its efficacy at relieving symptoms of heart failure, pericardiectomy is 
associated with a high peri-operative mortality rate which was not influenced by 





































Constrictive pericarditis is a curable cause of heart failure that occurs as a result of 
fibrous thickening of the pericardial sac that surrounds the heart. Renowned 
Spanish physician Avenzoar (1113 – 1162) described serofibrinous pericarditis in the 
middle ages. (1) In 1669, Richard Lower1, the pre-eminent physician in the court of 
Charles II of England noted ‘dyspnoea and intermittent pulse in a patient with 
constrictive pericarditis.’(2) The pericardial knock of constrictive pericarditis was 
first described in 1842 by Dominic Corrigan2(3) while pulsus paradoxus, common in 
constrictive pericarditis was first described by Adolf Kussmaul3 in 1873. (4) In 1929, 
Edward Doles Churchill performed the first pericardiectomy for adhesive 
pericarditis in the USA. (5) 
 
The visceral and parietal layers compose the normal pericardium. The visceral layer 
is a single sheet of ciliated mesothelial cells that line the entire outer surface of the 
cardiac chambers and the origins of the great vessels. This monolayer reflects 
outwards onto a thin fibrous sheet that completely surrounds the heart and origins 
of the great vessels to form the parietal pericardium. The pericardial space is 
created by this reflection and normally contains 15-50ml of clear serous fluid. The 
parietal pericardium is tethered to the diaphragm, the sternum and the vertebrae 
by ligaments that confer stability to the heart and great vessels during the cardiac 
cycle. Together, the pericardial bi-layer and space (with its constituent fluid) 
function to prevent excessive dilatation of the myocardium during diastole (thus 
preserving ventricular contractility by preventing excessive stretch in diastole), 
evenly distribute physical forces over the underlying cardiac chambers and act as a 
barrier to the contiguous spread of pathology from the extra-pericardial space to 
the heart. The limitation of cardiac dilatation afforded by the pericardium gives rise 
to the phenomenon of ventricular interdependence – overfilling of one ventricle 
reduces the filling of the other ventricle when the maximal filling volume allowed by 
                                                             
1 Richard Lower (1631-1691): English physician. Also named the Circle of Willis (after his mentor) and 
perfomed the first human blood transfusion in 1667. 
2
 Sir Dominic John Corrigan (1802 – 1880): Irish physician. Also described Corrigan’s sign and 
Corrigan’s pulse of aortic valve insufficiency 
3
 Adolf Kussmaul (1822-1902): Noted German physician and clinician. Apprenticed under Rudolf 
Virchow. Notable for many eponyms in modern medicine including Kussmaul’s breathing, Kussmaul’s 




the compliance of the parietal pericardium is reached (usually 15-20% in excess of 
the normal filling volume). (6) Exaggerated ventricular interdependence is seen in 
many disease states of the pericardium including constrictive pericarditis.  
 
In constrictive pericarditis, hypertrophied, fibrotic, adherent and at times calcified 
visceral and parietal pericardium have reduced compliance thus preventing 
adequate filling of the ventricles in diastole, with systolic function usually 
preserved. Fibrosis in constrictive pericarditis occurs over a long time as a result of 
recurrent or chronic inflammation of the pericardium due to various causes.  Some 
of these causes are shown in Table 1. Figure 1 demonstrates pericardial adhesion 
and thickening in a heart recovered at autopsy from a patient with tuberculous 
constrictive pericarditis while figure 2 is the microscopic appearance of the same 
heart illustrating the hypertrophy and fibrosis of the visceral pericardium. Figure 3 
illustrates extension of fibrosis into the myocardium in the same patient; this may 
occur in cases of longstanding constrictive pericarditis.  In a minority of patients 
with constrictive pericarditis (20%), the pericardium is not thickened i.e. < 3mm. (7-
9)  
Causes of constrictive pericarditis 
1. Unknown antecedents 
2. Post idiopathic pericarditis 
3. Infections 
-Bacterial: Streptococcus pneumonia, Staphylococcus aureus, Tuberculosis 
-Fungi: histoplasmosis, coccidioidomycosis 
-Viral: Coxsackie B 
      4. Connective Tissue Diseases: Rheumatoid Arthritis, Systemic Lupus Erythematosus 
      5. Maligancy: Primary mesothelioma, metastatic disease from lung, breast, lymphoma, melanoma 
      6. Post-trauma 
      7.   Post cardiac surgery 
      8. Post radiation therapy 
      9. Drug therapy: methysergide 
     10. Rare causes: Sarcoidosis, post-myocardial infarction, Rheumatic heart disease 










When the heart is constricted, the rigid pericardium does not transmit negative 
(inspiratory) intrathoracic pressure to the cardiac chambers. This negative pressure 
is, however, transmitted to the (unconstricted) pulmonary veins causing a 
diminution in transfer of pulmonary venous blood to the left heart with reduced 
trans-mitral flow and thus underfilling the left ventricle. (1) This negative pressure 
simultaneously causes increased venous return to the right heart causing increased 
trans-tricuspid flow and right ventricular volume in diastole. This volume increase is 
accompanied by elevation in diastolic right ventricular pressure and subsequent 
shift of the interventricular septum to the left (to accommodate the volume 
increase) in deference to ventricular free wall which is constricted by a rigid 
pericardium. This further reduces left ventricular filling and subsequent stroke 
volume and illustrates the exaggerated ventricular interdependence for which 
constrictive pericarditis is known. (6,8) The opposite occurs during expiration.  
 
Patients with pericardial constriction present mainly with longstanding signs and 
symptoms of predominantly right heart failure as pericardial constriction causes 
systemic congestion out of proportion to pulmonary congestion. (8) The symptoms 
include abdominal and lower limb swelling and effort intolerance developing 
insidiously over months to years. Table 2 highlights common signs in patients with 
pericardial constriction. The Vogelpoel-Beck sign* is of particular interest as it is 
eponymously named after two physicians who practiced at Groote Schuur Hospital 
Fig 1: Postmortem specimen 
of a heart with tuberculous 
constrictive pericarditis 
demonstrating thickening 
and fibrosis of the visceral 
pericardium 
Fig 2: Microscopic appearance of the 
heart in Fig. 1 showing a hypertrophied 
and fibrotic pericardium overlying the 
myocardium 
Fig 3: Microscopic appearance of the heart in 
Fig. 1 showing the fibrotic process extending 
into the myocardium as can occur in 




in the past century; it describes the transient sudden splitting of the second heart 
sound at the onset of inspiration as the aortic valve closes earlier than expected due 
to the underfilling of the left ventricle. (10) It commonly accompanies a significant 
pulsus paradoxus as the same mechanism underlies both signs. Severe constriction 
can present as cardiac cirrhosis with jaundice and protein-losing enteropathy. (11)  
Physical signs in constrictive pericarditis 
Physical sign   Frequency of observation 
Sinus tachycardia   47 (70%; persistent atrial fibrillation in 2) 
Significant pulsus paradoxus  32 (48%) 
Raised jugular venous pulse  67 (100%) 
Apex palpable   39 (58%) 
Pericardial knock   14 (21%) 
Increased cardiac dullness  17 (25%)   
Heart sounds soft   51 (76%) 
Third heart sound   30 (45%) 
Vogelpoel-Beck sign*   24 (36%) 
Hepatomegaly   67 (100%) 
Ascites    60 (89%) 
Oedema    63 (94%) 
Table 2: Physical signs noted by a single observer in 67 patients with constrictive pericarditis (Adapted from Strang JI. 
Tuberculous Pericarditis in Transkei(12) 
 
A definitive diagnosis of pericardial constriction depends on the presence of 
pericardial thickening and demonstration of changes in cardiac haemodynamics 
arising from reduced pericardial complicance. The electrocardiogram (ECG) 
commonly demonstrates small QRS complexes, sinus tachycardia and widespread T-
wave flattening or inversion. (8,13) In pure constrictive pericarditis, the chest x-ray 
reveals a normal sized heart with evidence of pulmonary congestion or pleural 
effusions and sometimes, pericardial calcification. On echocardiography, a 
thickened pericardium is represented by an echo-bright pericardium. 
Echocardiography with doppler measurement is used to demonstrate 




include exaggerated septal wall shift towards the left ventricle with inspiration, 
dilatation and diminished collapse of the inferior venacava and hepatic veins with 
inspiration, rapid early diastolic (e wave) deceleration and blunted late diastolic (a 
wave) velocities on trans-mitral and trans-tricuspid inflow doppler measurement 
with respiratory variation. (7,8,14) Tissue doppler imaging especially of mitral 
annular velocity and 2-dimensional speckle tracking to detect longitudinal and 
circumfrential myocardial deformation are echocardiographic techniques that are 
especially of use in differentiating pericardial constriction from restrictive 
cardiomyopathy. (1) Pericardial thickening (> 3mm thick), calcification and 
abnormal septal motion can be demonstrated by Computed Tomography (CT) 
scanning. (8) Cardiac Magnetic Resonance Imaging (MRI) can also demonstrate 
pericardial thickening, calcification and abnormal septal motion.  The presence of 
pericardial adhesions which can be seen on tagged cine MRI images is a very 
reliable sign of pericardial constriction. (8) MRI can further demonstrate the 
presence of myocardial inflammation, fibrosis and atrophy which may be useful in 
prognostication and clinical decision making regarding management. (13) 
 
Cardiac catheterisation is used to demonstrate the haemodynamic features of 
pericardial constriction especially when the diagnosis is in doubt. The typical 
findings include elevated atrial pressures, elevated right and left end-diastolic 
ventricular pressures with equalisation of the end-diastolic pressures of all four 
chambers (within 5mmHg of each other) and the dip-and-plateau configuration of 
the ventricular diastolic pressures. (8) The most specific haemodynamic feature of 
constrictive pericarditis is the demonstration of enhanced ventricular 
interdependence manifesting as an increase in the amplitude of the right 
ventricular (RV) pressure tracing with a concomitant decrease in the amplitude of 
the left ventricular (LV) pressure tracing with inspiration – the systolic area index. 
(7,15) This change in systolic area with respiration distinguishes pericardial 








Management of pericardial constriction with diuretics achieves symptomatic relief 
but does not address the underlying problem. Persistent symptoms despite 
adequate diuresis usually necessitates pericardiectomy – surgical excision of the 
diseased pericardium. (9,14) Pericardiectomy is a major procedure that involves 
thoracotomy with or without cardiopulmonary bypass and carries a 30-day 
mortality of up to 10%. (9) Pericardiectomy cures most patients of their symptom 
but up to 30% of patients may still report symptoms of pericardial constriction years 
after undergoing pericardiectomy due to a combination of disease and surgical-
related factors. (7) 
 
A review of the literature on constrictive pericarditis and pericardiectomy was 
conducted with a view to understanding the different experiences of clinicians 
Figure 4: In constrictive pericarditis (A), 
inspiration causes less filling of the LV, and 
the amplitude of LV pressure tracing 
decreases (yellow shaded area) as compared 
with expiration. The RV pressure tracing 
increases with inspiration (orange shaded 
area). This discordant pressure change 
between the LV and RV occurs in 
constrictive pericarditis.  
In restrictive cardiomyopathy (B) the 
changes in LV and RV systolic pressures with 
respiration are concordant. During 
inspiration the amplitude of the RV pressure 
tracing decreases (orange shaded area) as 
compared with expiration. The amplitude of 
the LV pressure tracing (yellow shaded area) 
is unchanged during inspiration and 
expiration. There is early rapid filling, 
elevation and end-equalization of the LV and 
RV pressures in both cases (dip-and-plateau 
configuration) 
 (Adapted from Talreja et al. Constrictive 
Pericarditis in the Modern Era. Novel 
Criteria for Diagnosis in the Cardiac 




involved in the management of patients with pericardial constriction worldwide and 
comparing this to local practice. A literature search of Pubmed and Medline using 
the keywords ‘constrictive pericarditis’, ‘pericardiectomy’ and ‘HIV/AIDS’ was 
carried out. Among others, the aims were to explore the causes of constrictive 
pericarditis around the world, to determine the mortality following pericardiectomy 
for constrictive pericarditis and understand the factors influencing mortality, to 
explore the effect of Human Immunodeficiency Virus/ Acquired Immune Deficiency  
Syndrome (HIV/AIDS) on the clinical profile of constrictive pericarditis and outcomes 
after pericardiectomy and to compare clinical and haemodynamic parameters 
before and after pericardiectomy. Original reports, review articles, professional 
society guidelines and case reports relevant to achieving the aims set out were 
collated and reviewed. 
 
 
Causes of Constrictive Pericarditis 
The aetiology of pericardial constriction displays a dual pattern – infective causes 
predominate in the developing world while non-infective causes prevail in the 
developed world. Tuberculosis infection is the predominant cause in the developing 
world.  Tuberculosis accounted for 65% of cases in patients undergoing 
pericardiectomy for constrictive pericarditis in one study in China (16) with similar 
studies in Ghana, India, South Korea and Turkey revealing a prevalence rate of 
63.6%, 61%, 42.4% and 38% respectively. (17-20) Fennell estimated that 
tuberculosis was the cause of constriction in all 109 patients that underwent 
pericardiectomy at a single centre in South Africa. (21)  Other bacterial infections 
that account for constrictive pericarditis in the developing world include 
Staphylococcus aureus and Haemophilus influenza. (22)  In contrast, tuberculosis 






The aetiology of pericardial constriction in the majority of patients in developed 
countries is unknown with 33 – 45% of patients undergoing pericardiectomy having 
no readily identifiable cause. (23-26) It is assumed that a significant portion of these 
cases is due to prior viral pericarditis. (25) Other causes identified include 
connective tissue diseases, prior cardiac surgery, prior mediastinal irradiation and 
uraemia.(27) While still the predominant cause, idiopathic causes are on the decline 
in recent years (24) while chest irradiation and prior cardiac surgery are becoming 
increasingly identified as causes in the developed world. (23-25) By contrast, the 
HIV/AIDS epidemic means that tuberculosis continues to be the leading cause of 
pericardial constriction in the developing world. 
 
 
Pericardiectomy: Mortality and its determinants 
Pericardiectomy offers the prospect of curing chronic constrictive pericarditis and is 
advocated when symptoms persist despite optimal medical therapy. (9) The 
removal of the diseased pericardium is done via a midline sternotomy or left 
anterolateral  thoracotomy. Left anterolateral thoracotomy allows the surgeon 
greater access to the ventricular pericardium without extensive mobilisation of the 
heart while midline sternotomy allows easier access to the aorta and right atrium in 
case cardiopulmonary bypass is required. Primary installation of cardiopulmonary 
bypass is not recommended due to the risk of bleeding with systemic 
heparinisation. (9) Complete resection of the diseased pericardium should be 
attempted as far as is possible as this has been proven to have better 
haemodynamic and mortality outcomes than incomplete pericardiectomy. (9,28,29) 
Failure to completely resect the pericardium is usually due to intra-operative 
haemodynamic instability or advanced disease with myocardial involvement and 
extensive pericardial calcification.  
 
The reported peri-operative mortality following pericardiectomy for pericardial 




reported peri-operative mortality (in-hospital + 30-day mortality rates) in a 
selection of studies spanning different regions and time periods. It is of note that 
perioperative mortality in the past two decades has declined slightly but remains 
high in most centres at 6-10%.  The causes of early mortality following 
pericardiectomy are ventricular arrhythmias, respiratory failure, sepsis, low-output 
cardiac failure and post-operative renal failure, with the latter two accounting for 
most deaths. (16,23,24,30) Mortality due to low-output cardiac failure is mainly due 
to pre-surgically unrecognised presence of myocardial atrophy or fibrosis (see figure 
3) (9) One year survival following pericardiectomy was reported at 93.7% in one 
single centre study from China(16) while 1-year, 5-year, and 10-year survival rates 
were 82.5%, 64.3%, and 49.2%, respectively from a single centre in the United 
States of America. (27) These survival statistics mirror what is commonly reported in 




















Author* Country of 
study 




Bashi V,  et al India 1954 - 1985 118 16 
Bertog SC, et al USA 1977 - 2000 163 6.1 
Cinar B, et al Turkey 1990 - 2005 70 8.6 
Tokuda Y, et al Japan 2008 - 2012 346 10 
George TJ, et al USA 1995 - 2010 98 7.1 
Ling LH, et al USA 1985 - 1995 135 6 
McCaughan, et 
al 
USA 1936 - 1982 231 14 
Ghavidel, et al  Iran 1994 - 2006 45 4.4 
Tettey M, et al Ghana 2000 - 2005 11 0 
Chen RF, et al Taiwan 1990 - 2003 23 8.7 
Szabo C, et al Germany 1988 - 2012 89 7 
Lin Y, et al China 2005 - 2010 51 3.9 
Bozbuga N, et al Turkey 1985 - 2002 36 6 
Ariyoshi T, et al Japan 2000 - 2011 16 12.5 
 Fennel  (1982) South Africa ? 109 3.6 
Arsan, et al  Turkey  1983 - 1993 105 10.5 
Tirilomis, et al Germany 1970 - 1990 71 5.6 





Numerous factors are reported to predict mortality following pericardiectomy. 
While a few are repeatedly found by different authors to be predictors of mortality, 
the majority of factors identified do not reproduce their mortality effect when 
looked at in other settings. Aetiology of constrictive pericarditis is the only factor 
that has good reproducibility as a predictor of long-term mortality in different 
settings with pre-operative functional status (New York Heart Association, NYHA*), 
left ventricular ejection fraction, renal dysfunction and the need for 
cardiopulmonary bypass at time of surgery being less reproducible but regularly 
reported predictors of mortality. Advanced age (30), longer duration of symptoms 
(31), higher Child-Pugh Score (32), hypoalbuminaemia (27), hyponatraemia (23), 
higher pulmonary artery pressures (23), higher right atrial pressures (33), increased 
early mitral valve inflow velocity (19), hyperbilirubinaemia (33) and ascites (29) are 
infrequently reported to predict mortality after pericardiectomy for constrictive 
pericarditis. Pericardial calcification has not been shown to predict mortality. (23)  
 
In numerous studies, the aetiology of constrictive pericarditis has been shown to be 
a predictor of long term mortality with post-irradiation disease having the worst 
prognosis while idiopathic constrictive pericarditis has the best prognosis. George, 
et al found prior irradiation to be an independent predictor of 10 year mortality (HR 
3.19, 95% CI 1.19 – 8.55, p=0.02) with 5-year survival differing by aetiology of 
constriction (idiopathic, post-surgery and post-radiation 5-year survivals of 79.8%, 
55.9%, and 11.0%, respectively; p < 0.001) (27) Numerous other authors have found 
a similar pattern with poor long-term outcome in patients with post-irradiation 
compared to those with idiopathic causes for pericardial constriction. (23,24,26) 
The study by Szabo, et al found that all 5 patients with irradiation-induced disease 
had died within 5 years of surgery. (26)  Tuberculous, uraemic and post-infarction 
constrictive pericarditis have survival statistics comparable to idiopathic pericardial 
constriction. (26,30) The higher mortality in patients with post-irradiation 






Poor pre-operative functional class as measured by the NYHA classification has also 
been frequently found to determine mortality. NYHA Class 4 (dyspnoea at rest) was 
found to predict peri-operative mortality and major morbidity (OR 3.85, 95% CI 
1.77–8.35, p<0.0001) in a nationwide Japanese study (34) and was found to be a 
predictor of poor survival at 10 and 15 years after pericardiectomy in studies 
conducted in Germany and the USA respectively. (24,26) It also negatively predicted 
both peri-operative  and late mortality in 71 patients that underwent 
pericardiectomy in Germany. (33) The higher mortality related to a poor pre-
operative functional class has led to many clinicians and professional society 
guidelines advocating pericardiectomy early in the course of constrictive 
pericarditis. (9) 
 
Left ventricular dysfunction manifested by a reduced ejection fraction or other 
measures of cardiac dysfunction has also been shown to be a predictor of mortality 
following pericardiectomy.  Ha and colleagues undertook pre-operative cardiac 
catheterisation in 40 patients with pericardial constriction and found that those 
with abnormal left ventricular contractility and relaxation properties had longer in-
hospital stay post pericardiectomy, higher  peri-operative mortality  and higher 
mortality two years after pericardiectomy compared to those in whom these indices 
were normal. (35) Reduced left ventricular ejection fraction was found to negatively 
predict long term survival in a retrospective study involving 163 patients over a 24-
year period. (23) Other authors have, however, found that left ventricular ejection 
fraction as assessed at echocardiography could not predict surgical outcome (19,36) 
The study by Kang  et al looked at multiple parameters on echocardiography in 85 
patients and found that only higher early diastolic mitral valve inflow velocity could 
independently predict mortality following pericardiectomy. (19) 
 
Pre-operative abnormal renal function (high serum creatinine) has also repeatedly 
been shown to be an independent predictor of mortality following pericardiectomy. 
Pre-operative renal failure was found to predict peri-operative mortality (OR 2.62, 




centre study in China found that it predicted a higher 1-year mortality after 
pericardiectomy. (16) Bertog and colleagues found that worse renal function 
predicted poor long-term survival in their single centre study. (23) 
 
Also frequently reported to predict mortality is the need for cardiopulmonary 
bypass at surgery. George, et al showed that the use of cardiopulmonary bypass 
conferred a higher likelihood of death at 30 days post-surgery (HR 21.2, 95% CI 
1.81–248.44, p=0.02) (27) while another study reported 2.46 higher odds of death 
at 30 days. (34) Not surprisingly, cardiopulmonary bypass predicts higher peri-
operative mortality as most practitioners use it only in situations of intra-operative 
haemodynamic instability such as occurs with massive bleeding or severe 
myocardial dysfunction. 
 
HIV/AIDS, constrictive pericarditis and pericardiectomy 
HIV/AIDS and related opportunistic infections form a significant burden of disease in 
the developing world. (37) Tuberculosis is the predominant opportunistic infection 
in patients with HIV/AIDS. (37) Effusive tuberculous pericarditis is the commonest 
cardiovascular manifestation of tuberculosis in HIV-seropositive individuals (38) and 
dual infection is associated with a 6-month mortality rate greater than  twice that of 
tuberculous pericarditis alone - 40% vs. 17%, p=0.001. (39) The majority of 
pericardial effusions in HIV-seropositive individuals were found to be tuberculous in 
origin in South Africa and Tanzania. (40,41) Constrictive pericarditis is one of the 
most serious sequelae of effusive tuberculous  pericarditis and is reported to occur 
in 17-60% of patients with effusive disease. (42) However, HIV-seropositive patients 
with effusive tuberculous pericarditis rarely progress to constrictive pericarditis. 
(38,43,44) In a randomised control trial of steroids vs. placebo in the treatment of 
effusive tuberculous pericarditis in HIV-seropositive patients, constriction was an 
infrequent outcome in the trial population and no deaths due to constrictive 
pericarditis occurred. (45) It is understood that the reduced incidence of 




HIV that renders the patient unable to mount an immune response to the 
tuberculoproteins in the pericardium. (29,38,44,45-47) Given the high 6-month 
mortality associated with co-infection with HIV and tuberculous pericarditis and the 
fact that fibrosis is a delayed element of the pericardial immune response, it is 
conceivable that death occurs before clinical pericardial constriction can occur. This 
observation has also been alluded to by other authors. (42,45) No studies have 
looked at the effect of CD4 cell count or the use of Combination Anti-Retroviral 
Therapy (CART) on the progression to constrictive pericarditis in patients with 
effusive tuberculous pericarditis.  
 
As a result of the infrequency of development of tuberculous constrictive 
pericarditis in HIV-seropositive individuals, there are no published studies that have 
looked at pericardiectomy and its outcomes in such patients. It is expected that 
with the recent increase in access to CART in the management of HIV, more patients 
with effusive tuberculous pericarditis will go on to develop pericardial constriction 
due to the reduction in immunosuppression associated with the use of CART in HIV.   
 
Pre- and post pericardiectomy clinical and haemodynamic features 
All pre- and post pericardiectomy comparative studies have shown improvements in 
the clinical and selected haemodynamic profiles of the patients surveyed.  Complete 
normalisation of cardiac haemodynamics is reported in 60% of patients. (9) A widely 
reported measure of fluid status, the central venous pressure (CVP), has been 
shown to decrease early on after pericardiectomy thus implying a reduction in the 
volume status of the patients. A significant drop in mean CVP (pre 15.3±3.7mmHg; 
post 8.8±3.1 mmHg, p<0.001) was reported in one series with 16 patients (48) while 
a nearly 50% drop in CVP was reported in another series with 89 patients. (26) Kang 
and colleagues showed a non-significant CVP drop in their series (19) whereas 
Bozbuga and colleagues showed a significant drop in CVP after pericardiectomy (pre 
14±4.2mmHg; post 7.4±2.1mmHg, p<0.004) (30) Post-operative reduction in CVP 





Pre and post-pericardiectomy comparisons of echocardiographic features have also 
been undertaken with varying results.  The left ventricular ejection fraction (LVEF), a 
widely reported echocardiographic feature, has not been shown to change much 
after surgery. (19,49)  Senni and colleagues conducted extensive echocardiographic 
examinations before and after pericardiectomy and found that diastolic filling 
characteristics remained abnormal in a substantial number of patient and that this 
correlated well with symptoms of residual constriction. (49) In a cohort of 28 
patients with echocardiographic tricuspid regurgitation (TR) and constrictive 
pericarditis undergoing pericardiectomy (but not tricuspid valve surgery), TR was 
found to have remained the same in 50% of patients, worsened in 29% and 
improved in 22% of the patients. (50) The study reported no impact on survival in 
the cohort that had undergone tricuspid valve surgery (for TR) concomitantly with 
pericardiectomy. Thirty patients with tuberculous constrictive pericarditis that 
underwent catheterisation before and after pericardiectomy showed a significant 
reduction in right ventricular end-diastolic pressure (pre 12.7±4.4mmHg; post 
7.2±2.7mmHg, p=0.015), a non-significant reduction in left ventricular end-diastolic 
pressure (pre 11.5±3.0mmHg; post 8.8±2.2mmHg, p=0.08) and a non-significant 
reduction in the pulmonary artery pressure (pre 20.0±4.4mmHg; post 
16.7±3.1mmHg, p=0.1) (30) 
 
The most often reported measure of efficacy of pericardiectomy is the NYHA 
functional class before and after surgery. Virtually all studies report improvements 
in NYHA class after pericardiectomy. These improvements are noted both in the 
short term and even after up to 15 years of follow up in survivors. 
(18,21,24,26,30,48,51) In general, most patients are in NYHA class 2 (dyspnoea with 
moderate exertion) or class 3 (dyspnoea with mild exertion) prior to 
pericardiectomy and report an improvement of atleast one or two classes. A few 
patients remain in the same functional class while even fewer report a worsening of 
functional class. A worsening of functional class after pericardiectomy is usually 




valvular heart disease or cardiomyopathy.  Figure 5 is a typical representation of 
NYHA class changes that take place with pericardiectomy and is adapted from a 





In summary, constrictive pericarditis is curable cause of chronic heart failure whose 
pathophysiological, haemodynamic and clinical features are well known. The 
aetiology of constrictive pericarditis varies by region with tuberculosis being the 
most predominant cause in the developing world. Pericardiectomy offers a chance 
to cure the syndrome and has been studied extensively in the developed world. The 
peri-operative mortality associated with pericardiectomy varies but can be as high 
as 10% and multiple factors that seem to predict mortality have been identified, 
mainly from studies in the developed world.  There is no consensus on which factors 
irrefutably predict outcome after pericardiectomy and results of studies carried out 
in the developed world are not necessarily applicable to the developing world due 






 In addition, the HIV/AIDS pandemic that currently afflicts the developing world 
changes many aspects of the disease and its management and calls for research 
from the developing world to answer specific pertinent questions that arise as a 
result of the unique nature of the disease in this setting. Besides a study in 1982, 
there has not been any further examination of pericardiectomy for constrictive 
pericarditis in South Africa. Of particular concern is the need to define the causes of 
constrictive pericarditis and the mortality following pericardiectomy for constrictive 
pericarditis in our setting. It is also important to ascertain which factors can be used 
to predict mortality following pericardiectomy in our setting in order to aid decision 
making and management of constrictive pericarditis given the limited resources at 
our disposal. The impact of HIV/AIDS on the clinical profile and outcomes after 
pericardiectomy also needs to be studied.  
 
A retrospective study of patients that have undergone pericardiectomy for 
constrictive pericarditis at Groote Schuur Hospital will be undertaken to try and 
answer some of the questions that remain unanswered in the management of 
constrictive pericarditis in South Africa. It will be the first opportunity in a long time 
to study this often forgotten condition and generate local data that will guide 
management going forward. It will also allow us to gauge how we compare to the 
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Background: Causes of constrictive pericarditis and predictors of peri-operative 
outcome following pericardiectomy are not clearly elucidated, especially in Africa, 
where disease characteristics differ from developed countries. Furthermore, the 
impact of HIV/AIDS on pericardial constriction and outcomes following surgery is 
unknown. We set out to investigate the causes of constrictive pericarditis, the 
outcomes after pericardiectomy and the predictors of mortality in Cape Town, 
South Africa during a 22-year period of high HIV/AIDS prevalence. 
Methods: A retrospective review of records of all patients who underwent 
pericardiectomy for constrictive pericarditis at Groote Schuur Hospital from 1 
January 1990 to 31 December 2012 was performed. 
Results: Of 121 patients, thirty six (29.8%) had proven tuberculosis, 74 (61.2%) 
presumed tuberculosis, six (5%) idiopathic, and 5 (4%) miscellaneous causes of 
constrictive pericarditis. Seventeen patients (14%) died peri-operatively with low 
cardiac output syndrome the main cause of mortality. In multivariable analysis, 
serum sodium (HR=0.88, 95%CI 0.80-0.97 p=0.009) and pre-operative New York 
Heart Association (NYHA) class IV (HR=3.42, 95%CI 1.29-9.08, p=0.014; compared 
with combined class I-III) were independent predictors of early mortality. There 
were 14 (11.6%) HIV positive patients with a mean CD4 cell count of 284 ± 133 
cells/µl. No early deaths occurred in the HIV positive patients.  
Conclusion: Tuberculosis is the main cause of constrictive pericarditis in South 
Africa. Despite its efficacy at relieving symptoms of heart failure, pericardiectomy is 
associated with a high peri-operative mortality rate which was not influenced by 








Not much is known about pericardiectomy for constrictive pericarditis in the 
developing world. This study is the largest on the subject emanating from Africa in 
the HIV/AIDS era. It highlights the importance of early referral for pericardiectomy 
























Constrictive pericarditis (CP) is a treatable cause of heart failure. Fibrosed, non-
compliant parietal and visceral pericardium impede ventricular filling in diastole 
thereby reducing stroke volume and  giving rise to systemic venous congestion. (1) 
Causes of pericardial fibrosis are varied (2) with studies showing that infective 
causes are prevalent in the developing world. (3-5) Pericardiectomy is the standard 
method of relieving pericardial constriction. (6) Outcomes after pericardiectomy 
and predictors of mortality have been studied extensively in the developed world 
(7-9) but only a few small studies have examined the causes and outcome of 
patients with constrictive pericarditis requiring pericardiectomy in Africa. (5, 10) 
Due to differences in disease patterns and resource availability, the findings of 
studies conducted in the developed world may not be an accurate reflection of the 
experience of constrictive pericarditis requiring pericardiectomy in Africa. 
Over the past 20 years, South Africa has seen an increase in the prevalence of 
pulmonary and extra-pulmonary tuberculosis (TB) largely driven by increases in the 
incidence and prevalence of human immunodeficiency virus/Acquired Immune 
Deficiency Syndrome (HIV/AIDS). (11) The effect of the increase in HIV/AIDS on the 
clinical characteristics of constrictive pericarditis and outcomes after 
pericardiectomy is not known.   
We conducted a study to examine the causes, determinants of 30-day mortality, 
functional outcomes and the impact of HIV/AIDS on the clinical profile and 
outcomes after pericardiectomy at Groote Schuur Hospital in Cape Town, South 




A retrospective review of records of all patients that underwent pericardiectomy for 
constrictive pericarditis at the Chris Barnard Division of Cardiothoracic Surgery of 
Groote Schuur Hospital was undertaken. Patients that underwent pericardiectomy 
between 1 January 1990 and 31 December 2012 were eligible for the study. Patient 




and symptoms, haemodynamic and laboratory data, operative techniques and 
outcomes) were entered into a standardised data capture sheet. Patients whose 
records could not be found were excluded from the study. The diagnosis of 
constrictive pericarditis was based on typical clinical and echocardiographic findings 
with confirmation of pericardial fibrosis and constriction intra-operatively (6).  
Commonly encountered clinical features included peripheral oedema with 
hepatomegaly and ascites, pulsus paradoxus and pleural effusions while 
echocardiography typically revealed pericardial thickening, paradoxical septal 
motion, dilated inferior venacavae and typical respiratory variation in doppler flow 
across the mitral/tricuspid valves.  Cardiac catheterisation and/or computed 
tomography (CT) scanning were done in cases of diagnostic uncertainty to confirm 
pericardial thickening and constriction. All patients had surgery via median 
sternotomy with particular care being taken to free up the entire ventricular 
epicardium, apex and diaphragmatic surface of the heart.  Once freed, the 
pericardium was removed anteriorly extending laterally close to the phrenic nerves 
with the posterior pericardium left in-situ after being freed from the epicardium 
(total pericardiectomy). Any resection less than this was considered partial 
pericardiectomy.  Cardiopulmonary bypass was used at the discretion of the 
surgeon or when haemodynamic instability prevented adequate exposure of the 
adherent pericardium. Presumed tuberculosis as a cause for constrictive pericarditis 
was defined as the presence of a history of pulmonary tuberculosis or the initiation 
of empiric anti-tuberculous therapy by the attending physician, prior to 
pericardiectomy. Proven tuberculosis was defined as the presence of 
Mycobacterium tuberculosis in pericardial tissue/fluid or sputum by microscopy or 
culture. The presence of caseous pericardial tissue at surgery was also considered 
confirmatory of tuberculosis. Peri-operative mortality was defined as death from 
any cause occurring during the index hospitalisation or within 30 days of surgery 
even if the patient had been discharged from hospital. The study was approved by 







Categorical data were compared using the 2 test and continuous data were 
compared using the t test. The Kaplan-Meier method was used to calculate 
probabilities of death events, and the log-rank test was used to compare these 
probabilities by group. Cox proportional hazards regression models were fitted to 
determine risk factors associated with mortality. In this analysis, and due to small 
numbers, NYHA class I-III were combined and modelled as baseline risk vs NHYA 
class IV. Variables found to be significantly associated with the outcome were 
included in the final model. The proportionality assumption of the Cox models was 
tested using –ln[–ln (survival)] curves and regression of scaled Schoenfeld residuals 
on functions of time. All tests were two-sided, and a p-value <0.05 was considered 
significant. Statistical analysis was conducted using SPSS software (Version 20). 
 
RESULTS 
A total of 128 patients underwent pericardiectomy for constrictive pericarditis 
during this period; seven were excluded from the study because of missing records.  
Of the 121 patients in the study, 79 (65.3%) were male and the mean age was 41.3 
± 16.1 years (range 14 – 74). There were two cases of recurrent constriction 
requiring re-pericardiectomy 2 months after initial surgery. Total pericardiectomy 
was possible in 105 patients (88.2%) with 14 (11.8%) undergoing partial 
pericardiectomy. Five (4.1%) patients underwent concomitant mitral valve repair, 
one patient underwent concomitant aortic valve replacement with coronary artery 
bypass grafting. Baseline characteristics stratified by mortality status are 
summarised in Table I.  
One hundred and ten (90.9%) patients had constrictive pericarditis due to either 
proven or presumed tuberculosis; 36 (29.8%) had proven tuberculosis while 74 
(61.2%) had presumed tuberculosis. Six (4.9%) patients had idiopathic constrictive 
pericarditis while other causes each accounted for 1 patient (Figure 1). The patient 
with radiation-induced constrictive pericarditis had undergone chest irradiation for 




HIV negative. Table II highlights causes of constrictive pericarditis reported in similar 
studies worldwide (3,4,7-9,12-17). Sixty three (52.1%) patients underwent 
diagnostic cardiac catheterisation with only one case of coronary artery disease 
documented at coronary angiography. All 63 patients had elevation and 
equalisation of diastolic pressures with the dip-and-plateau configuration typical of 
constrictive pericarditis. 18 patients (14.9%) underwent cardiac CT scanning. Intra-
operative complications included 27 (22.3%) cases of inadvertent myocardial wall or 
major vessel injury with bleeding, tachyarrhythmias requiring cardioversion (n=6, 
5%) and phrenic nerve injury (n=2, 1.7%). Low output cardiac failure was the 
commonest post-operative complication (n=80; 66.1%) with sternal wound sepsis 
(n=9, 7.4%), other site sepsis (n=9, 7.4%), acute kidney injury (n=9, 7.4%), re-
thoracotomy for bleeding (n=4, 3.3%), re-thoracotomy for placement of ventricular-
assistive devices (n=2, 1.7%), respiratory complications (n=6, 5%), neuropsychiatric 
complications (n=5, 4.1%), and tachyarrhythmias (n=3, 2.5%) accounting for other 
post-operative complications. There was no intra-operative mortality. Seventeen 
(14%) patients died post-operatively while still in hospital, one of whom had 
undergone concomitant mitral valve repair. Nine (52.9%) of these patients were in 
NYHA class IV prior to surgery. Low output cardiac failure was directly or indirectly 
responsible for death in 11 patients while acute kidney injury was implicated in the 
deaths of 6 patients. Post-operative sepsis was implicated in 4 deaths and post-
operative bleeding, rapid atrial fibrillation and respiratory failure were each 
implicated in 1 death.  One patient’s death was sudden and unexplained while the 
cause of death in two patients was not apparent from their records. Figure II shows 
the overall Kaplan-Meier survival plot for the study population. The 30-day survival 
rate in this study was 86%. Completeness of pericardiectomy did not have any 
effect on peri-operative mortality (Hazard ratio (HR) =1.74, 95% CI 0.61 – 4.97, 
p=0.077). The period during which pericardiectomy was undertaken did not affect 
peri-operative mortality (1990 – 2000 mortality: 8/46 (17%); 2001 – 2012 mortality 
9/75(12%); p=0.41). There was no difference in mortality between patients with 




In univariable Cox proportional hazards regression analysis, variables significantly 
associated with peri-operative mortality were pre-operative New York Heart 
Association (NYHA) class (class IV HR =4.99, 95% CI 1.92-13.03, p=0.001, compared 
to combined class I-III), pre-operative total daily dose of diuretic (furosemide) 
(HR=1.003, 95% CI 1.001-1.006, p=0.019), pre-operative serum creatinine (HR=1.09, 
95% CI 1.01-0.03, p=0.002) and pre-operative serum sodium (HR= 0.86, 95% CI 0.80 
– 0.93, p<0.0001). In multivariable analysis, serum sodium (HR=0.88, 95% CI 0.80-
0.97, p=0.009) and pre-operative NYHA class (class IV HR=3.42, 95% CI 1.29-9.08, 
p=0.014 compared to combined class I-III) were independent predictors of early 
mortality (Table III). 
Fourteen of 96 patients (14.6%) tested were found to be HIV positive on serology 
while the HIV status of 25 of the 121 study patients (20.6%) was unknown. Most of 
the patients with an unknown HIV status underwent pericardiectomy in the early 
1990s before the advent of routine pre-operative HIV testing. The baseline 
characteristics of the HIV positive and HIV negative patients are compared in Table 
IV (online supplement). Women were over-represented in the HIV positive group (8 
female (57.1%) vs. 6 male (42.9%); p=0.024) while haemoglobin (mean = 13.2 ± 1.7 
g/dl vs. 12.1 ± 2.0 g/dl, p=0.031) and serum creatinine (mean = 86 ± 25 µmol/l vs. 68 
± 9 µmol/l, p=0.012) were found to be significantly lower in the HIV positive cases 
compared with the HIV negative cases. No HIV positive patients underwent surgery 
on cardiopulmonary bypass. The average CD4 count at time of surgery was 284 ± 
133 cells/µl (range = 50-435 cells/µl). Nine of the 14 (64.3%) patients were taking 
combination anti-retroviral therapy (CART) at the time of surgery. No peri-operative 
deaths occurred in the HIV positive group.  
Pre-operative and 30-day post-operative NYHA functional status was available for 
73 (60.3%) of the 121 patients. (Figure III, online supplement) Most showed 
improvement in functional status (p<0.0001) with the majority changing from NYHA 
class II to class I (n=25, 34.2%) and NYHA class III to class I (n=21, 28.8%). Seven 
(9.6%) patients remained in the same functional class while two (2.7%) patients had 




surgery, the majority of the patients had NYHA class III symptoms (n=35, 47.9%) 
with a majority reporting class I symptoms 30 days after surgery. (n=50, 68.5%)  
 
DISCUSSION 
We have studied the aetiology of constrictive pericarditis and early outcomes after 
pericardiectomy in 121 patients over a 22 year period in a single centre from Sub-
Saharan Africa. To the best of our knowledge, this is the first large study of the 
aetiology and predictors of peri-operative outcome of constrictive pericarditis in the 
HIV/AIDS era in Africa. Our results have some variation from those reported in 
recent similar series covering the same subject. (7-9,14,17,18) Although our findings 
are relevant to practitioners in South Africa and other developing countries, the 
globalization of health implies practitioners in North America and Europe are likely 
to treat increasing numbers of immigrants and refugees with tuberculosis and its 
sequelae such as constrictive pericarditis. (19) 
One hundred and ten (90.9%) of the patients in our study had either proven or 
presumed tuberculosis as a cause for constrictive pericarditis. This is higher than 
reported in other series from China, Ghana, India, South Korea and Turkey where TB 
remains a major cause of constrictive pericarditis. (Table II) Tuberculosis accounted 
for 65% of cases in patients undergoing pericardiectomy for constrictive pericarditis 
in a study from China (14) with studies in Ghana, India, South Korea and Turkey 
revealing a prevalence rate of 63.6%, 61%, 42.4% and 38% respectively. (3-5,13) 
Only 36 (32.7%) of the 110 patients had a proven diagnosis of tuberculous 
constrictive pericarditis. This difference highlights the diagnostic difficulty faced by 
clinicians in resource limited settings where TB is endemic – without recourse to 
advanced diagnostic techniques  to determine the aetiology of constrictive 
pericarditis, the clinician, armed only with knowledge of the background high 
prevalence of TB, is forced to treat empirically for TB in order to avoid the technical 
difficulty and associated morbidity/mortality that comes with performing 
pericardiectomy on patients with active/untreated tuberculous pericarditis. (10)  
This common scenario is a likely contributor to the large number of cases of TB 




a cause for constrictive pericarditis in South Africa. Fennell, in an earlier South 
African study, alluded to similar difficulties and a similar course of action in 
managing constrictive pericarditis. (10) He surmised that all 109 patients in his 
cohort had TB constrictive pericarditis. (10)  Despite the possibility that TB 
pericarditis  as a cause for constrictive pericarditis may be over-reported in this 
study, there is little doubt that TB remains the leading cause of effusive and 
subsequent constrictive pericarditis in South Africa. A local study found TB to 
account for 69.5% of large pericardial effusions in this region of South Africa. (20)  
The use of imaging studies such as CT scan or magnetic resonance imaging (MRI) 
may help to reduce diagnostic uncertainty in situations where active pericarditis / 
myopericarditis (as might occur in active TB pericarditis) needs to be excluded. (21) 
It is also worth noting the rarity with which mediastinal irradiation, autoimmune 
diseases and other causes of constrictive pericarditis commonly reported in 
developed countries are seen in our setting (Table II) (7,8,17) Only one patient 
underwent pericardiectomy for radiation-induced constrictive pericarditis in 22 
years at our centre compared to 17 patients in 10 years in the study by Ling and 
colleagues. (7) 
Our study has found a higher peri-operative mortality than that reported in similar 
series worldwide. We have reported a 30-day mortality rate of 14% whereas others 
have reported mortality rates in the range of 6 – 10%. (7,12,16,17) The only recent 
study to show similar peri-operative mortality is that of Ariyoshi and colleagues 
which had 12.5% mortality but only among 16 patients (22), while McCaughan et al 
reported a peri-operative mortality rate of 14% in a cohort of 231 patients from 
1932 to 1986. (15) Bashi and colleagues reported a 16% peri-operative mortality 
rate in 118 patients who underwent surgery between 1954 and 1985. (3) Mortality 
in our study was not influenced by the decade during which pericardiectomy took 
place. Unlike Chowdhury and colleagues who found partial pericardiectomy to 
predict peri-operative mortality, we found no difference in outcome in those that 
had total vs partial pericardiectomy using a similar surgical technique to that 
utilised by Chowdhury and colleagues. (23) Kang, et al who described total and 




We have found pre-operative NYHA class to be independently associated with peri-
operative mortality in our population.  Compared with pre-operative combined 
NYHA I, II and III functional status, patients with pre-operative NYHA IV symptoms 
had higher risk of peri-operative death. Other authors have found a similar 
statistically significant association between pre-operative NYHA IV status and early 
mortality - Tokuda and others found 3.85 higher odds of early death (p<0.0001) (16) 
while Tirilomis and colleagues reported increased risk of death with pre-operative 
NYHA class IV symptoms (p<0.01) (24) Pre-operative NYHA class IV signifies more 
severe disease with a greater degree of cardiac dysfunction that is more likely to 
result in peri-operative morbidity and mortality. In studies that have looked at long 
term outcomes after pericardiectomy, pre-operative NYHA class IV has also been 
found to be a predictor of mortality. (7,17) 
We have also found pre-operative serum sodium to be inversely associated with 30-
day mortality i.e.  lower serum sodium is associated with increased early mortality.  
Bertog, et al also reported that low serum sodium was associated with a higher 
overall mortality in their cohort of 163 patients. (8) A low serum sodium is a 
reflection of severe fluid overload in gross heart failure (dilutional hyponatraemia) 
or the use of higher doses of diuretic (as occurred in our study) in patients with 
severe fluid overload. Alternatively, hyponatraemia reflects generalised electrolyte 
imbalance as a marker of severe illness such as would occur in syndrome of 
inappropriate anti-diuretic hormone (SIADH) or sick cell syndrome. (25) Although 
not so in our study, other factors found to be associated with 30-day mortality 
include left ventricular dysfunction (26), use of cardiopulmonary bypass (9,16) and 
pre-operative renal failure. (16)  
Low output cardiac failure was found to be a major contributor to mortality in our 
setting having occurred in 11 of 17 (64.7%) deaths. It was also found to be the 
predominant cause of peri-operative death by other authors. (7,8,14,27) Low-
output cardiac failure is mainly due to the presence of myocardial atrophy and/or 
fibrosis especially in cases of long-standing constriction. (6) Despite the use of 
inotropes, intra-aortic balloon pump and fluid resuscitation, a significant number of 




Fourteen (11.6%) patients in our study had serological evidence of HIV infection. To 
the best of our knowledge, this is the first study to document the prevalence, 
clinical characteristics and outcomes in HIV positive patients undergoing 
pericardiectomy for constrictive pericarditis. A recent nationwide study in the 
United States of America had less than 10 HIV positive patients out of a population 
of 3847 undergoing pericardiectomy. (28) The low frequency of HIV in our cohort 
may reflect the apparent protective effect of HIV infection on progression to 
constrictive pericarditis. (12,29-32) All HIV positive patients in our study had TB 
pericarditis as the cause of constrictive pericarditis (6 proven tuberculosis, 8 
presumed tuberculosis) The average CD4 count was 284 cells/µl indicating some 
degree of immunological integrity thereby increasing the likelihood of progression 
to pericardial constriction. A CD4 count of 284 cells/µl is higher than what we 
commonly see in other cases of extra-pulmonary TB and may be a result of the use 
of CART which, at 64.3%, is higher than what was seen in the background 
population during the bulk of the period of study. (33)  
The only significant differences between the HIV positive and negative populations 
are in gender (more female HIV positive patients), a lower (but still largely normal) 
haemoglobin in the HIV positive group and a lower creatinine which may reflect the 
reduced body habitus usually associated with HIV infection – these differences did 
not affect outcome between the two groups. There were no early deaths in the HIV 
positive population. The high prevalence of TB in our study and the pre-HIV era 
study by Fennell (10) suggests that the advent of HIV/AIDS has not affected the 
causality pattern of constrictive pericarditis in South Africa. Fennell reported in-
hospital mortality of 3%, whereas we found 30-day mortality of 14%. The outcome 
results of our study and those of Fennell are not comparable because of differences 
in the methods of the two studies. This study has shown that when TB constrictive 
pericarditis does occur in HIV positive patients, the clinical characteristics and peri-
operative outcome are comparable to what is seen in HIV negative patients.  
Despite higher than commonly reported peri-operative mortality, we have shown 
that most survivors experienced marked improvement in their effort tolerance as 




was available at both time points improved from NYHA class II and III pre-
operatively to class I effort tolerance at 30-days post surgery (p<0.0001). Ling et al 
reported similar improvements in a cohort of 93 late survivors after 
pericardiectomy. (7)  
In summary, our study has shown that although effective at relieving symptoms of 
constrictive pericarditis, pericardiectomy in Cape Town is associated with a high 
peri-operative mortality of 14%, mainly related to low output cardiac failure. Pre-
operative NYHA class IV and hyponatraemia have been shown to predict peri-
operative mortality. As expected, the prevalence of TB constrictive pericarditis is 
very high although the possibility exists that TB is over-reported as a cause for 
constrictive pericarditis. We have also shown that there are no major differences in 
the clinical profile and early outcomes in patients with HIV infection that undergo 
pericardiectomy for constrictive pericarditis, compared to their HIV negative 
counterparts. Our study illustrates the need for early recourse to pericardiectomy 
before symptoms deteriorate to NYHA class IV or severe fluid overload – delay may 
result in myocardial atrophy as a result of chronic myocardial constriction and leads 
to worse outcomes.  It also highlights the need to search for ways of reducing early 
mortality through improved management of post-pericardiectomy low cardiac 
output syndrome and the need for better diagnostic techniques in constrictive 














Our study was limited by the small number of missing patient records and missing 
data from available patient records due to the retrospective design of the study.  
Despite these limitations, the study has identified the prognostic role of low serum 
sodium and NYHA functional class IV as predictors of outcome. Furthermore, the 
study has a small number of HIV infected patients and can therefore not provide 
definitive information on the impact of HIV infection in patients with constrictive 
pericarditis requiring pericardiectomy. Finally, the follow-up period included the 
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Characteristic All, n=121 Alive, n=104 Died, n=17 p-value 
 
n (%) n (%) n (%) 
 Mean age, yrs  41.3 ± 16.1 40.2 ± 16.1 47.6 ± 14.7 0.08 
Gender 
   
0.546 
     Male 79(65.3) 69(66.3) 10(58.8) 
 
     Cause of constrictive pericarditis 
   
0.679 
     Tuberculosis 110(90.9) 95(91.3) 15(88.2) 
      Other 11(9.1) 9(8.7) 2(11.8) 
 Pre-op NYHA+ 
   
0.001 
     I 3(2.5) 2(1.9) 1(5.9) 
      II 38(31.4) 36(34.6) 2(11.8) 
      III 57(47.1) 52(50.0) 5(29.4) 
      IV 23(19) 14(13.5) 9(52.9) 
 Mean symptom duration, months   12.5 ± 22.4 5.3 ± 4.4  13.7 ± 23.9 0.154 
HIV Status 
   
0.274 
     HIV +ve 14(11.6) 14(13.5) 0(0.0) 
      HIV-ve 82(67.8) 69(66.3) 13(76.5) 
      HIV unknown 25(20.6) 21(20.2) 4(23.5) 
 Hypertension 12(9.9) 9(8.7) 3(17.6) 0.25 
Diabetes mellitus 3(2.5) 3(2.9) 0(0.0) 0.478 
Mean total daily diuretic dose*, mg  119 ± 101 109 ± 71 174 ± 192 0.014 
Mean weight, kg  65 ± 12 64.8 ± 12.2 66.1 ± 10.7 0.715 
Mean systolic BP¤, mmHg   111 ± 15 112 ± 15 108 ± 13 0.262 
Mean diastolic BP, mmHg   70 ± 11 71 ± 11 68 ± 11 0.288 
Mean pulse rate, beats per minute   89 ± 16 88 ± 16 95 ± 14 0.091 
Pulsus paradoxus 77(63.6) 68(65.4) 9(52.9) 0.323 
Ascites 92(76) 77(74) 15(88.2) 0.204 
S3 Knock 64(52.9) 57(54.8) 7(41.2) 0.297 




Hepatomegaly 108(89.3) 95(91.3) 13(76.5) 0.066 
Pericardial calcification¥  28(23.1) 25(24.0) 3(17.6) 0.562 
Atrial fibrillation 10(8.3) 7(6.7) 3(17.6) 0.13 
Low QRS amplitude 77(63.6) 63(60.6) 14(82.4) 0.084 
Mean LVEF
§
, %   57 ± 11 57 ± 11 58 ± 14 0.704 
Mean haemoglobin, g/dl   13.1 ± 1.7 13.1 ± 1.7 13.0 ± 1.5 0.759 
Mean serum sodium, mmol/l   137 ± 5 138 ± 4 133 ± 7 <0.0001 
Mean serum creatinine, µmol/l   83 ± 23 81 ± 18 99 ± 38 0.002 
Total pericardiectomy¢ 105(88.2) 93(90.3) 12(75) 0.077 
On cardio-pulmonary bypass 20(16.5) 15(14.4) 5(29.4) 0.123 
Post-operative inotropes 80(66.1) 63(60.6) 17(100) 0.001 
Mean post-op ICU stay, days  3.4 ± 2.3 3.4 ± 1.8 3.5 ± 4.4 0.96 
 
Table I: Baseline characteristics of study patients categorised by mortality status. Continuous variables are 
shown as mean with standard deviation in brackets while categorical variables are shown as the absolute value 
with percentage of the total in brackets 
± standard deviation; + New York Heart Association functional class; * diuretic used was furosemide; ¤ blood 
pressure; ¥ on CXR or at cardiac catheterisation; § Left ventricular ejection fraction, as measured on 
echocardiogram or at cardiac catheterization; ¢ anterior pericardium excised between phrenic nerves and 
posterior pericardium freed. Completeness of pericardiectomy could not be ascertained on one patient in each 
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Factor Univariate analysis Multivariate analysis 
Hazard Ratio (95%CI) p-value Hazard Ratio (95%CI) p-value 
Serum sodium 0.86(0.80-0.93) <0.0001 0.88(0.80-0.97) 0.009 
Serum creatinine 1.09(1.01-1.03) 0.002 1.01(0.99-1.03) 0.089 
Total daily dose (furosemide) 1.003(1.00-1.006) 0.02 1.00(0.99-1.01) 0.312 
NYHA  0.001  0.014 
    Class I-III 1  1  
    Class IV                              4.99(1.92-13.03)  3.42(1.29-9.08)  
 
Table III: Univariate and multivariate Cox proportional hazards regression models of factors 
























  n (%) n (%)   
 
Mean age, yrs  40.2 ± 16.1 32.1 ± 7.2 0.068 
Gender     0.024 
     Male 60(73.2) 6(42.9)   
Cause of constrictive pericarditis     0.256 
     TB 75(91.5) 14(100)   
     Other 7(8.5) 0(0.0)   
Pre-op NYHA     0.724 
     I 2(2.4) 0(0.0)   
     II 25(31.7) 4(28.6)   
     III 36(43.9) 8(57.1)   
     IV 18(22.0) 2(14.3)   
Mean symptom duration, months  12.6 ± 25.1 5.8 ± 5.1 0.316 
Hypertension 8(9.8) 0(0.0) 0.222 
Diabetes Mellitus 2(2.4) 0.(0.0) 0.555 
Mean total daily diuretic dose, mg  124 ± 115 126 ± 75 0.953 
Mean weight, kg 64.5 ± 12.7 64.6 ± 10.4 0.976 
Mean systolic BP, mmHg  111 ± 15 109 ± 12 0.629 
Mean diastolic BP, mmHg  70 ± 12 74 ± 9 0.154 
Mean pulse, bpm  89 ± 16 96 ± 16 0.121 
Pulsus paradoxus 53(64.6) 7(50) 0.296 
Ascites 65(79.3) 11(78.6) 0.953 
Diastolic knock 38(46.3) 8(57.1) 0.455 






*Mean CD4 count 284±133 cells/µl 
Table IV: Baseline characteristics of the 96 study patients with known HIV status. Continuous 
variables are shown as mean with standard deviation while categorical variables are shown as the 





Hepatomegaly 71(86.6) 13(92.9) 0.512 
Pericardial calcification 17(20.7) 3(21.4) 0.953 
Atrial fibrillation 7(8.5) 0(0.0) 0.256 
Low QRS amplitude 52(63.4) 10(71.4) 0.562 
Mean LVEF, %  56 ± 11 60 ± 13 0.241 
Mean haemoglobin, g/dl  13.2 ± 1.7 12.1 ± 2.0 0.031 
Mean serum sodium, mmol/l  136 ± 5 137 ± 2 0.721 
Mean serum creatinine, µmol/l  86 ± 25 68 ± 9 0.012 
Total pericardiectomy 71(88.8) 13(92.9) 0.646 
On cardio-pulmonary bypass 17(20.7) 0(0.0) 0.06 
Post-operative inotropes 56(68.3) 8(57.1) 0.413 
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may be submitted for online-only inclusion. A reference in the printed text will 
direct readers to the additional online content 
 No more than 35 references 
 A limit of 7 authors; exceptions are made for multi-center trials and can be 

























Appendix 2: Data collection sheet 
IMPI Trial Sub-Study: Pericardiectomy for Constrictive Pericarditis (1990 – 2012) 
Initials  Name  Surname  ID num  
Folder no  DOB  Age  Gender M F Priority Elec Urg Emerg 
DO Surgery  Cause of CP TB (p) TB (s) Idiopathic Other  
Leg swelling Y N Abd swelling Y N Pre-op NYHA I II III IV Other  
Duration (m)  Prev TB Y N TB presently Y N Duration of Rx  HIV +ve Y N U CD4  
HAART Y N Hypt Y N DM Y N IHD Y N Other  
Diuretic Lasix Dose  N O ACE-I Y N Other  Weight (kg)  
Height (cm)  BMI  sBP  dBP  Pulse  Pulsus Y N JVP R N  
Oedema Y N Ascites Y N Jaundice Y N S3 Knock Y N Creps Y N Pleural eff Y N 
Hepar Y N Other sign  Cardiomegally Y N Peric Ca2+ Y N 
AF Y N ECG V-rate  QRS  Ampl L N TWI Y N Other ECG  
Peric thick Y N Size (mm)  Peric eff Y N Size(mm)  IVC Dilated  Y N  
RV Press  Septal bounce Y N TR Y N LVEF  Other  
Catheter Y N LVEDP  RVEDP  Other  
CT Chest  Y N Findings  
MRI heart Y N Findings  
Hb  WCC  Creat  Na  K+  TBili  Alb  AST  
ALT  ALP  GGT  INR  AFB Status Pos Neg Unknown  
Histo result  
Approach M/sternotomy Other  Completion Total Partial CPB Y N 
Other procedure N Y  Intra op compl  
 Other op notes  
ICU Duration   Ventilated Y N Ionotropes Y N Vasopressin Y N IABP Y N 
ICU D/C date  D/C Home Date  Post op complications  
 
NYHA at 30d  Diuretic Lasix Dose  N Other  Oedema Y N JVP R N 
Echo Y N Findings  
NYHA at 6m  Diuretic Lasix Dose  N Other  Oedema Y N JVP R N 
Echo Y N Findings  
NYHA at 12m  Diuretic Lasix Dose  N Other  Oedema Y N JVP R N 
Echo Y N Findings  
Other notes: 
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Appendix 3: Faculty of Health Sciences (UCT) ethics approval 
66 
Appendix 4: Groote Schuur Hospital letter of authorisation 
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